COVID-19 Vaccine Express Strategy in Malawi: An Effort to Reach the Un-reach

Overview

Journal Vaccine

Specialty Allergy & Immunology

Date 2022 Jul 25

PMID 35871867

Authors

Ghanashyam Sethy

Mike Chisema

Lokesh Sharma

Krupal Joshi

Sanjay Singhal

Patrick Omar Nicks

Steve Macheso

Tedla Damte

Antoinette Eleonore Ba

Collins Mitambo

Mavuto Thomas

Beverly Laher

John Phuka

Affiliations

Soon will be listed here.

Abstract

Objectives: To establish the impact of "Covid-19 Vaccination express" (CVE) on vaccine uptake in Malawi.

Design: Retrospective cross-sectional study to compare the daily vaccine administration rate in CVE and routine covid vaccination (RCV). RCV data was collected from March 2021 to October 2021. The data regarding CVE was collected from 5 November 2021 to 31 December 2021. Data was collected regarding (1) the total number and type of vaccine doses administered and (2) Demographic details like age, gender, occupation, presence of comorbidities, the first dose, or the second dose of the people who received a vaccine.

Results: From March-December 2021, a total of 1,866,623 COVID-19 vaccine doses were administered, out of which 1,290,145 doses were administered at a mean daily vaccination rate of 1854 (95 % CI: 1292-2415) doses as a part of RCV, and 576,478 doses were administered at a mean daily vaccination rate of 3312 (95 % CI: 2377-4248) doses as a part of CVE. Comparing the mean daily doses (Astra Zeneca, AZ doses 1 & 2) administered in the CVE and RCV showed that the mean daily doses of AZ vaccine administered were significantly higher in the CVE (p < 0.05).

Conclusion: CVE successfully increased the uptake of the Covid-19 vaccine.

Citing Articles

Mortality risk information and health-seeking behavior during an epidemic.

Purcell H, Kohler I, Ciancio A, Mwera J, Delavande A, Mwapasa V Proc Natl Acad Sci U S A. 2024; 121(28):e2315677121.

PMID: 38959039 PMC: 11252761. DOI: 10.1073/pnas.2315677121.

Knowledge, attitudes and demographic drivers for COVID-19 vaccine hesitancy in Malawi.

Ndasauka Y, Twabi H, Kainja J, Gunde A, Makhumula-Mtimuni C Sci Rep. 2024; 14(1):9578.

PMID: 38671014 PMC: 11053073. DOI: 10.1038/s41598-024-60042-5.

References

Zavala E, Krubiner C, Jaffe E, Nicklin A, Gur-Arie R, Wonodi C . Global disparities in public health guidance for the use of COVID-19 vaccines in pregnancy. BMJ Glob Health. 2022; 7(2). PMC: 8882664. DOI: 10.1136/bmjgh-2021-007730. View

Abedin M, Islam M, Rahman F, Reza H, Hossain M, Hossain M . Willingness to vaccinate against COVID-19 among Bangladeshi adults: Understanding the strategies to optimize vaccination coverage. PLoS One. 2021; 16(4):e0250495. PMC: 8078802. DOI: 10.1371/journal.pone.0250495. View

Anderson R, Vegvari C, Hollingsworth T, Pi L, Maddren R, Ng C . The SARS-CoV-2 pandemic: remaining uncertainties in our understanding of the epidemiology and transmission dynamics of the virus, and challenges to be overcome. Interface Focus. 2021; 11(6):20210008. PMC: 8504893. DOI: 10.1098/rsfs.2021.0008. View

Moola S, Gudi N, Nambiar D, Dumka N, Ahmed T, Sonawane I . A rapid review of evidence on the determinants of and strategies for COVID-19 vaccine acceptance in low- and middle-income countries. J Glob Health. 2021; 11:05027. PMC: 8645216. DOI: 10.7189/jogh.11.05027. View

Wouters O, Shadlen K, Salcher-Konrad M, Pollard A, Larson H, Teerawattananon Y . Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021; 397(10278):1023-1034. PMC: 7906643. DOI: 10.1016/S0140-6736(21)00306-8. View

Strupat C, Shigute Z, Bedi A, Rieger M . Willingness to take COVID-19 vaccination in low-income countries: Evidence from Ethiopia. PLoS One. 2022; 17(3):e0264633. PMC: 8893640. DOI: 10.1371/journal.pone.0264633. View

Yasmin F, Najeeb H, Moeed A, Naeem U, Asghar M, Chughtai N . COVID-19 Vaccine Hesitancy in the United States: A Systematic Review. Front Public Health. 2021; 9:770985. PMC: 8650625. DOI: 10.3389/fpubh.2021.770985. View

de Paula N, Brown C . Vaccine equity: a stress test for planetary health. Lancet Planet Health. 2021; 5(11):e758-e759. PMC: 8580504. DOI: 10.1016/S2542-5196(21)00291-6. View

Wariri O, Nkereuwem E, Erondu N, Edem B, Nkereuwem O, Idoko O . A scorecard of progress towards measles elimination in 15 west African countries, 2001-19: a retrospective, multicountry analysis of national immunisation coverage and surveillance data. Lancet Glob Health. 2021; 9(3):e280-e290. PMC: 7900524. DOI: 10.1016/S2214-109X(20)30481-2. View

10.

Katey D, Abass K, Garsonu E, Gyasi R . Depopulation or vaccination? Tackling the COVID-19 crisis in prisons in Africa. Health Justice. 2022; 10(1):12. PMC: 8897616. DOI: 10.1186/s40352-022-00176-8. View

11.

Dorman C, Perera A, Condon C, Chau C, Qian J, Kalk K . Factors Associated with Willingness to be Vaccinated Against COVID-19 in a Large Convenience Sample. J Community Health. 2021; 46(5):1013-1019. PMC: 8033546. DOI: 10.1007/s10900-021-00987-0. View

12.

Mobarak A, Miguel E, Abaluck J, Ahuja A, Alsan M, Banerjee A . End COVID-19 in low- and middle-income countries. Science. 2022; 375(6585):1105-1110. DOI: 10.1126/science.abo4089. View

13.

Adebisi Y, Alaran A, Bolarinwa O, Akande-Sholabi W, Lucero-Prisno D . When it is available, will we take it? Social media users' perception of hypothetical COVID-19 vaccine in Nigeria. Pan Afr Med J. 2021; 38:230. PMC: 8140724. DOI: 10.11604/pamj.2021.38.230.27325. View

14.

Lawal L, Bello M, Murwira T, Avoka C, Yusuf Maaruf S, Harrison Omonhinmin I . Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward. Hum Vaccin Immunother. 2022; 18(1):2034457. PMC: 9009957. DOI: 10.1080/21645515.2022.2034457. View

15.

Rustagi N, Choudhary Y, Asfahan S, Deokar K, Jaiswal A, Thirunavukkarasu P . Identifying psychological antecedents and predictors of vaccine hesitancy through machine learning: A cross sectional study among chronic disease patients of deprived urban neighbourhood, India. Monaldi Arch Chest Dis. 2022; 92(4). DOI: 10.4081/monaldi.2022.2117. View

16.

Leibowitz A, Livaditis L, Daftary G, Pelton-Cairns L, Regis C, Taveras E . Using mobile clinics to deliver care to difficult-to-reach populations: A COVID-19 practice we should keep. Prev Med Rep. 2021; 24:101551. PMC: 8428151. DOI: 10.1016/j.pmedr.2021.101551. View